Company Watch: Open Orphan could realise £20 million in first non-core asset IPO

Co-founder Cathal Friel has indicated that a series of spinouts could unlock £750 million for shareholders in the Dublin-based pharma company

Barry J Whyte

Chief Feature Writer @whytebarry
18th April, 2021
Company Watch: Open Orphan could realise £20 million in first non-core asset IPO
Cathal Friel: planning an IPO for Open Orphan Pic: Fergal Phillips

Open Orphan, the Dublin-listed pharmaceutical services company run by Cathal Friel, will launch an initial public offering (IPO) of one of its non-core assets in June in a move that could raise more than £20 million.

It is likely to be the beginning of a busy period of stock market listings for Friel, who has in the past identified a further three non-core assets that could be publicly listed.

In a recent investor presentation, Friel...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Related Stories

Stripe to recruit hundreds of software engineers in Dublin

WebDoctor valued at €48m after VentureWave investment

Tullow Oil swings back to profit for the first half of 2021